Q1 2019 Theravance Biopharma Inc Earnings Call Transcript
Ladies and gentlemen, good afternoon. At this time, I'd like to welcome everyone to the Theravance Biopharma Conference Call. (Operator Instructions) Today's conference call is being recorded.
And now I would like to turn the call over to Jessica Stitt, Vice President, Finance and Investor Relations. Please go ahead.
Good afternoon, everyone, and thank you for joining our conference call and webcast to discuss our first quarter 2019 financial results and outlook. Joining us are Rick Winningham, Chief Executive Officer; Brett Haumann, Chief Medical Officer; and Frank Pasqualone, Chief Commercial Operations Officer. Following some prepared remarks, we will open the call for questions. A copy of the press release and the slides accompanying this call can be downloaded from our website, or you can call Investor Relations at (650) 808-4045, and we'll be happy to assist you.
As always, I will remind you that this conference call will contain forward-looking
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |